Archived: Previous Version
Archived: Depression in Children and Adolescents: Screening
Original Release Date: March 2009
This version of this topic is currently archived and inactive. It should be used for historical purposes only.
Archived: Recommendation Summary
Summary of Recommendations
|Adolescents, 12-18 years of age, in Clinical Practices with Systems of Care|
The USPSTF recommends screening of adolescents (12-18 years of age) for major depressive disorder (MDD) when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and follow-up.
|Children, 7-11 years of age|
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening of children (7-11 years of age).
This recommendation updates the USPSTF's 2002 recommendation on Screening for Depression with respect to children and adolescents. Go to http://ww.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/depression-in-adults-screening to view the updated recommendation for adults.
Go to the Clinical Considerations section for suggestions for practice when the evidence is insufficient.
Select for a Clinical Summary of this recommendation and suggestions for clinical practice.
Archived: Related Information for Health Professionals
Internet Citation: Final Update Summary: Depression in Children and Adolescents: Screening. U.S. Preventive Services Task Force. July 2019.